期刊文献+

康复新液保留灌肠治疗溃疡性结肠炎临床研究 被引量:6

下载PDF
导出
摘要 目的:观察康复新液保留灌肠治疗溃疡性结肠炎的临床疗效。方法:将130例溃疡性结肠炎患者随机分为两组,治疗组用康复新液50 ml加0.9%NaCl溶液50 ml稀释成100 ml,保留灌肠2周;对照组用思密达6 g加用0.9%NaCl溶液100 ml保留灌肠2周,观察疗效和不良反应。结果:治疗组显效率68%,总有效率94%;对照组显效率30%,总有效率82%,治疗中均未见明显的不良反应。结论:康复新液治疗溃疡性结肠炎疗效明显,经济实用。
作者 韦秀贤
出处 《吉林医学》 CAS 2013年第26期5388-5389,共2页 Jilin Medical Journal
  • 相关文献

参考文献2

二级参考文献15

  • 1潘国宗 刘彤华 见:潘国宗 曹世植9. 主编.溃疡性结肠炎[A].见:潘国宗,曹世植9.,主编.现代胃肠病学.第Ⅰ版[C].北京:科学出版社,1994.1246-1247.
  • 2潘国宗 刘彤华.Crohn病[A].见:潘国宗 曹世植 主编.现代胃肠病学[C].北京:科学出版社,1994.1154.
  • 3樋渡信夫 渡边浩光 前川浩树 等.溃疡性结肠炎的诊断标准与诊断进展[J].炎症性肠疾患胃与肠,1997,32(3):271-278.
  • 4欧阳钦.炎症性肠病的诊治进展.见:孟宪镛主编.实用消化病诊疗学.第2版.上海:世界图书出版社,2006.362-84.
  • 5Ouyang Q, Tandon R, Goh KL, et al. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol,2005: 21:408-413.
  • 6Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, con sensus, and implications. Gut, 2006, 55:749-753.
  • 7Zheng JJ. Clinical aspects of ulcerative colitis in China's Mainland. Chin J Dig Dis, 2006, 7:71-75.
  • 8Hanauer SB, Sandborn W, Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol, 2001, 96: 635- 643.
  • 9Stange EF, Travis SP, Vermeire S, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut, 2006, 55 Suppl 1:i1- i15.
  • 10Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut, 2004, 53 Suppl 5: Ⅴ1-Ⅴ16.

共引文献2074

同被引文献29

  • 1魏克伦,杨于嘉,姚裕家,杜立中,王庆红.中国住院新生儿流行病学调查[J].中国当代儿科杂志,2009,11(1):15-20. 被引量:213
  • 2王凡,朱保权,徐丁,张妮.肠型脂肪酸结合蛋白在小儿危重症胃肠功能衰竭早期诊断中的价值[J].中华儿科杂志,2007,45(9):712-713. 被引量:7
  • 3Funaoka H, Kanda T, Kajiura S, et al. Development of a High-specificity Sandwich ELISA System for the Quantification of HumanIntestinal Fatty Acid-Binding Protein (I—FABP) Concentrations.Immunological Investigations, 2011,40(3):223-242.
  • 4Pelsers M, Hermens WT, Glatz J. Fatty acid-binding proteins asplasma markers of tissue injury. Clinica Chimica Acta, 2005,352(1-2):15-35.
  • 5Schurink M, Kooi EM, Hulzebos CV, et al. Intestinal fatty acid-binding protein as a diagnostic marker for complicated anduncomplicated necrotizing enterocolitis: a prospective cohort study.PLoS One, 2015,10(3):e121336.
  • 6Heida FH,Hulscher JB, Schurink M, et al. Intestinal fatty acid-binding protein levels in necrotizing enterocolitis correlate withextent of necrotic bowel: results from a multicenter study. J PediatrSurg, 2015,50(7):1115-1118.
  • 7Drenckpohl D, McConnell C,Gaffney S, et al. Randomized trial ofvery low birth weight infants receiving higher rates of infusion ofintravenous fat emulsions during the first week of life. Pediatrics,2008,122(4):743-751.
  • 8Bagci S, Eis-Hubinger AM, Franz AR, et al. Detection of astrovirusin premature infants with necrotizing enterocolitis. Pediatr Infect Dis J,2008, 27(4):347-350.
  • 9高群.浅谈对新生儿护理的方法[J].吉林医学,2009,30(20):2470-2471. 被引量:5
  • 10叶小丽.新生儿疾病筛查现状分析与护理研究进展[J].吉林医学,2011,32(24):5174-5175. 被引量:6

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部